Advertisement

Creating R&D Incentives for Medicines for Neglected Diseases

An Economic Analysis of Parallel Imports, Patents, and Alternative Mechanisms to Stimulate Pharmaceutical Research

  • Authors
  • Frank Müller-Langer

Table of contents

  1. Front Matter
    Pages I-XIX
  2. Frank Müller-Langer
    Pages 1-6
  3. Frank Müller-Langer
    Pages 28-97
  4. Frank Müller-Langer
    Pages 140-199
  5. Frank Müller-Langer
    Pages 231-233
  6. Back Matter
    Pages 235-297

About this book

Introduction

Virtually no research is targeted at developing medicines for tropical diseases as the expected market returns from R&D into these diseases in the private pharmaceuticals sector are too low. Frank Müller-Langer addresses the market failure with respect to R&D for medicines for tropical diseases and the lack of short-term access to affordable medicines in poor countries. The author analyzes additional push and pull mechanisms to stimulate R&D for pharmaceutical products alongside patent protection which may help mitigate the problem of those consumers in poor countries who lack access to affordable medicines. Furthermore, he reasons that a global regime of banning parallel trade from low-income countries to high-income countries is desirable from a developing country’s perspective.

Keywords

Forschung & Entwicklung Forschung und Entwicklung Innovation Medicines Patente Patents R&D

Bibliographic information

  • DOI https://doi.org/10.1007/978-3-8349-8323-7
  • Copyright Information Gabler Verlag | GWV Fachverlage GmbH, Wiesbaden 2009
  • Publisher Name Gabler
  • eBook Packages Business and Economics
  • Print ISBN 978-3-8349-1730-0
  • Online ISBN 978-3-8349-8323-7
  • Buy this book on publisher's site
Industry Sectors
Pharma
Biotechnology